The C-Terminal Domains of the PB2 Subunit of the Influenza A Virus RNA Polymerase Directly Interact with Cellular GTPase Rab11a.
GTP Phosphohydrolases
/ metabolism
Influenza A virus
/ enzymology
Nucleoproteins
/ metabolism
Protein Binding
Protein Domains
Protein Transport
/ genetics
Proteomics
RNA, Viral
/ metabolism
RNA-Dependent RNA Polymerase
/ genetics
Ribonucleoproteins
/ metabolism
Scattering, Small Angle
Viral Proteins
/ genetics
Virus Replication
/ genetics
PB2 polymerase subunit
RNA polymerase
Rab11a
cytoplasmic trafficking
influenza virus
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
09 03 2022
09 03 2022
Historique:
pubmed:
13
1
2022
medline:
29
4
2022
entrez:
12
1
2022
Statut:
ppublish
Résumé
Influenza A virus (IAV) contains a segmented RNA genome that is transcribed and replicated by the viral RNA polymerase in the cell nucleus. Replicated RNA segments are assembled with viral polymerase and oligomeric nucleoprotein into viral ribonucleoprotein (vRNP) complexes which are exported from the nucleus and transported across the cytoplasm to be packaged into progeny virions. Host GTPase Rab11a associated with recycling endosomes is believed to contribute to this process by mediating the cytoplasmic transport of vRNPs. However, how vRNPs interact with Rab11a remains poorly understood. In this study, we utilized a combination of biochemical, proteomic, and biophysical approaches to characterize the interaction between the viral polymerase and Rab11a. Using pulldown assays, we showed that vRNPs but not complementary RNPs (cRNPs) from infected cell lysates bind to Rab11a. We also showed that the viral polymerase directly interacts with Rab11a and that the C-terminal two-thirds of the PB2 polymerase subunit (PB2-C) comprising the cap-binding, mid-link, 627, and nuclear localization signal (NLS) domains mediate this interaction. Small-angle X-ray scattering (SAXS) experiments confirmed that PB2-C associates with Rab11a in solution forming a compact folded complex with a 1:1 stoichiometry. Furthermore, we demonstrate that the switch I region of Rab11a, which has been shown to be important for binding Rab11 family-interacting proteins (Rab11-FIPs), is also important for PB2-C binding, suggesting that IAV polymerase and Rab11-FIPs compete for the same binding site. Our findings expand our understanding of the interaction between the IAV polymerase and Rab11a in the cytoplasmic transport of vRNPs.
Identifiants
pubmed: 35019720
doi: 10.1128/jvi.01979-21
pmc: PMC8906434
doi:
Substances chimiques
Nucleoproteins
0
PB2 protein, Influenzavirus A
0
RNA, Viral
0
Ribonucleoproteins
0
Viral Proteins
0
RNA-Dependent RNA Polymerase
EC 2.7.7.48
GTP Phosphohydrolases
EC 3.6.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0197921Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200835/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R009945/1
Pays : United Kingdom
Références
J Gen Virol. 2016 Sep;97(9):2058-2072
pubmed: 27449792
PLoS Pathog. 2021 May 10;17(5):e1009517
pubmed: 33970958
Cold Spring Harb Perspect Med. 2020 Sep 1;10(9):
pubmed: 31871230
PLoS Pathog. 2014 Mar 06;10(3):e1003971
pubmed: 24603687
Structure. 2006 Aug;14(8):1273-83
pubmed: 16905101
PLoS Pathog. 2013;9(5):e1003358
pubmed: 23671419
J Virol. 2011 May;85(10):5228-31
pubmed: 21411538
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
pubmed: 10801978
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):E4238-45
pubmed: 24145413
Nat Commun. 2020 Jan 7;11(1):23
pubmed: 31911620
Cell. 2020 May 14;181(4):877-893.e21
pubmed: 32304664
Nat Commun. 2019 Apr 9;10(1):1629
pubmed: 30967547
Nat Microbiol. 2019 Nov;4(11):1781-1789
pubmed: 31332385
PLoS One. 2011;6(6):e21123
pubmed: 21731653
Annu Rev Virol. 2016 Sep 29;3(1):411-427
pubmed: 27741407
Eur J Med Genet. 2006 Jan-Feb;49(1):29-36
pubmed: 16473307
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15416-21
pubmed: 17030804
Nature. 2014 Dec 18;516(7531):361-6
pubmed: 25409151
Nat Microbiol. 2019 Oct;4(10):1750-1759
pubmed: 31209309
PLoS Pathog. 2021 Sep 2;17(9):e1009321
pubmed: 34473799
Nat Commun. 2017 Nov 9;8(1):1396
pubmed: 29123131
Nature. 2020 Nov;587(7835):638-643
pubmed: 33208942
Nat Commun. 2014 Sep 16;5:4816
pubmed: 25226414
Trends Biochem Sci. 2012 Feb;37(2):49-57
pubmed: 22154230
Cell Host Microbe. 2010 Jun 25;7(6):440-51
pubmed: 20542248
PLoS Pathog. 2012;8(12):e1003019
pubmed: 23236273
Vaccine. 2012 Dec 7;30(51):7359-67
pubmed: 23063835
Nat Rev Microbiol. 2015 Jan;13(1):28-41
pubmed: 25417656
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Nat Rev Microbiol. 2021 May;19(5):303-318
pubmed: 33495561
Virol J. 2020 Jul 16;17(1):107
pubmed: 32677963
J Gen Virol. 2009 Jun;90(Pt 6):1398-1407
pubmed: 19264657
J Synchrotron Radiat. 2020 Sep 1;27(Pt 5):1438-1446
pubmed: 32876621
Trends Cell Biol. 2014 Jul;24(7):407-15
pubmed: 24675420
Vaccine. 2012 Dec 7;30(51):7411-7
pubmed: 23063830
J Cell Sci. 2016 Apr 15;129(8):1697-710
pubmed: 26940915
J Virol. 2011 May;85(9):4143-56
pubmed: 21307188
Nature. 2006 Jan 26;439(7075):490-2
pubmed: 16437116
J Virol. 2011 Jul;85(13):6117-26
pubmed: 21525351
Nature. 2019 Sep;573(7773):287-290
pubmed: 31485076
Front Cell Dev Biol. 2019 Jan 09;6:176
pubmed: 30687703
J Virol. 2017 Mar 13;91(7):
pubmed: 28122973
Cell Rep. 2020 Jun 30;31(13):107823
pubmed: 32610124
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Virol. 2010 Jun;84(12):5848-59
pubmed: 20357086
Nature. 2015 Nov 5;527(7576):114-7
pubmed: 26503046
Cold Spring Harb Perspect Med. 2021 Sep 1;11(9):
pubmed: 32341065
Methods. 2006 Dec;40(4):303-11
pubmed: 17101441
Biochem Soc Trans. 2009 Oct;37(Pt 5):1032-6
pubmed: 19754446
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16604-9
pubmed: 24067651